June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effect of dexamethasone on the phenotype of cultured corneal endothelial cells
Author Affiliations & Notes
  • Veronique Beaulieu Leclerc
    Axe médecine regénératrice, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, Québec, QC, Canada
    Ophtalmologie, Université Laval, Quebec, QC, Canada
  • Olivier Roy
    Axe médecine regénératrice, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, Québec, QC, Canada
    Ophtalmologie, Université Laval, Quebec, QC, Canada
  • Stephanie Proulx
    Axe médecine regénératrice, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, Québec, QC, Canada
    Ophtalmologie, Université Laval, Quebec, QC, Canada
  • Footnotes
    Commercial Relationships Veronique Beaulieu Leclerc, None; Olivier Roy, None; Stephanie Proulx, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1141. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Veronique Beaulieu Leclerc, Olivier Roy, Stephanie Proulx; Effect of dexamethasone on the phenotype of cultured corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1141.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Human corneal endothelial cells (HCEC) tend to lose their endothelial morphology in culture, a phenomenon known as endothelial-to-mesenchymal transition (EndMT). The purpose of this study was to evaluate the ability of a synthetic glucorticoïd, dexamethasone (Dex), to block EndMT of cultured HCEC.

Methods: HCEC (n=4 populations, passage 2) with a mixed phenotype were passaged and grown in a proliferation medium containing Dex (1 µM). The medium was changed for a maturation medium still containing Dex after reaching confluency and the cells were cultured for another 7 days. Two other HCEC populations were cultured in the proliferation medium alone until confluency and Dex was added to the maturation medium for 7 days. Cultures without Dex were used as controls. Morphology was assessed by phase contrast microscopy. Immunofluorescence and western blots were performed (endothelial functionality markers ZO-1, Na+/K+ATPase and pan-cadherin; mesenchymal markers α-SMA and type I collagen) in order to analyze the phenotype.

Results: Adding Dex during the proliferation phase of HCEC had no significant effect on the morphology of the cells. However, morphology was improved during the maturation phase. Immunofluorescence and western blot analysis showed that when Dex was used in both cultivation phases, it reduced the expression of mesenchymal markers, compared to the controls. Dex also improved the localisation of ZO-1 at cell junctions and increased Na+/K+ATPase expression. When Dex was only used in the maturation phase, the morphology greatly improved, from mixed/fibroblastic to endothelial. Expression of type I collagen was not significantly different (p>0.05) and expression of α-SMA was higher than the controls. Cells that went through the maturation phase in the presence of Dex had an increased expression of the endothelial markers ZO-1, Na+/K+ATPase and pan-cadherin as well as a better cytolocalisation when compared to the controls (without Dex) and compared to cells in the proliferation phase.

Conclusions: Addition of Dex to the culture media, in both culture phases, helps to acquire an endothelial phenotype. Results also demonstrate that the maturation of HCEC in the right conditions plays a role in the establishment of an endothelial phenotype and expression of function-related proteins.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×